Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $74.3 million.

  • Perspective Therapeutics' Shares Outstanding rose 1002.8% to $74.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.3 million, marking a year-over-year increase of 1002.8%. This contributed to the annual value of $70.7 million for FY2024, which is 15077.71% up from last year.
  • As of Q3 2025, Perspective Therapeutics' Shares Outstanding stood at $74.3 million, which was up 1002.8% from $74.3 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Shares Outstanding ranged from a high of $142.1 million in Q3 2022 and a low of $14.2 million during Q4 2022
  • Its 5-year average for Shares Outstanding is $84.6 million, with a median of $74.1 million in 2025.
  • Its Shares Outstanding has fluctuated over the past 5 years, first tumbled by 8999.49% in 2022, then surged by 15077.71% in 2024.
  • Over the past 5 years, Perspective Therapeutics' Shares Outstanding (Quarter) stood at $142.0 million in 2021, then crashed by 89.99% to $14.2 million in 2022, then skyrocketed by 98.3% to $28.2 million in 2023, then skyrocketed by 150.78% to $70.7 million in 2024, then grew by 5.19% to $74.3 million in 2025.
  • Its Shares Outstanding was $74.3 million in Q3 2025, compared to $74.3 million in Q2 2025 and $74.1 million in Q1 2025.